Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / United Kingdom

EMEA Approves First Pre-Pandemic Bird Flu Vaccine

May 2008 | Industry News

The European Medicines Agency (EMEA) has given GlaxoSmithKline (GSK) approval to market its human avian-influenza vaccine Prepandrix. The licence will allow the company to negotiate money-spinning supply contracts with governments, NGOs and companies within the 27 EU member

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Emerging Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Emerging Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
GSK To Expand Production In Romania

Industry / United Kingdom UK pharmaceutical firm GlaxoSmithKline (GSK) has decided to move production of anti-depressant drug Seroxat/Paxil (paroxetine) to Romania as part of an ongoing effort to improve operational efficiencies....
July 2008
Wholesalers Concerned By Growing Use Of DTP Distribution

Industry / United Kingdom The European Association of Pharmaceutical Full-Line Wholesalers (GIRP) has used its most recent annual general meeting (June 2008) to voice its growing concerns over direct-to-pharmacy (DTP) distribution....
June 2008
Looking To The UK For Biotech Collaborations

Industry / United Kingdom The first steps have been made towards potential collaborations between biotechnology companies in Lithuania and the UK, as a delegation from the Baltic state visited Chesterford Research Park, near...
May 2008
GSK To Target Emerging Markets

Industry / United Kingdom Like all of its peers, UK-based multinational GlaxoSmithKline (GSK) is adapting to the pharmaceutical industry's new and challenging operating paradigm. While the demand for innovative medicines continues...
May 2008
GSK Cuts HIV Drug Prices For Russia

Companies / United Kingdom In effort to control the country's growing HIV/AIDS epidemic, UK firm GlaxoSmithKline (GSK) has entered into a deal with the Russian government to supply three of its antiretroviral drugs at discounted...
September 2006
Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS